Literature DB >> 15763679

On the errors in assessment of severity of involuntary movements using surface EMG.

Takao Hashimoto1, Masaomi Shindo, Hiroshi Morita, Nobuo Yanagisawa, Shu-ichi Ikeda.   

Abstract

Surface electromyogram (SEMG) is a useful tool to depict involuntary movements, but evaluation of the intensity of such movements with SEMG over multiple recording instances requires awareness of factors influencing quantified SEMG signals. We investigated the differences in the amplitude of SEMGs due to electrode displacement in isometric voluntary contraction in the upper arm, forearm and lower leg in 8 healthy men. The SEMGs of gross muscle activity simultaneously recorded with 4 electrode pairs from the agonist and antagonist sides in 3 displacement conditions with respect to parallel position, interelectrode distance, and rotation were compared. The amount of EMG integration (equivalent to the average SEMG amplitude) of each electrode pair was compared to the reference electrode pair with interelectrode distance of 40 mm placed on the center of the tested muscles. The average EMG difference ratios ranged 1.1-2.2%/mm in parallel shift, 1.0-1.9%/mm in distance shift, and 0.3-0.6%/degree in rotation shift. Displacement error of electrodes in separate recording instances should be reduced using anatomical landmarks, when SEMG is applied as a quantitative method to evaluate change in the states of involuntary movements.

Entities:  

Mesh:

Year:  2004        PMID: 15763679     DOI: 10.1016/j.jelekin.2004.11.003

Source DB:  PubMed          Journal:  J Electromyogr Kinesiol        ISSN: 1050-6411            Impact factor:   2.368


  1 in total

1.  Effect of glenohumeral forward flexion on upper limb myoelectric activity during simulated mills manipulation; relations to peripheral nerve biomechanics.

Authors:  Marinko Rade; Michael Shacklock; Saara M Rissanen; Stanislav Peharec; Petar Bačić; Corrado Candian; Markku Kankaanpää; Olavi Airaksinen
Journal:  BMC Musculoskelet Disord       Date:  2014-09-02       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.